cytarabine and Primary Myelofibrosis

cytarabine has been researched along with Primary Myelofibrosis in 40 studies

Research

Studies (40)

TimeframeStudies, this research(%)All Research%
pre-199015 (37.50)18.7374
1990's12 (30.00)18.2507
2000's8 (20.00)29.6817
2010's5 (12.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Laurizohn, C; Machaczka, M1
Borchmann, P; Engert, A; Monsef, I; Rancea, M; Skoetz, N; Will, A1
Abdulkadyrov, K; Fominykh, M; Martynkevich, I; Polushkina, L; Shuvaev, V; Udaleva, V1
Endo, Y; Iwanaga, T; Miura, N; Miyoshi, N; Momoi, Y1
Chen, Y; Li, Z; Lu, Q1
Ishigatsubo, Y; Kanamori, H; Sakai, R; Takabayashi, M1
Ball, ED; Bashey, A; Broome, HE; Carrier, E; Hoh, CK; Holman, P; Lane, T; Sun, C; Tanner, ML1
Buesche, G; Buhr, T; Fonatsch, C; Freund, M; Ganser, A; Georgii, A; Hasford, J; Hecker, H; Hehlmann, R; Heimpel, H; Heinze, B; Holgado, S; Kreipe, HH; Pfirrmann, M; Schmeil, A; Tobler, A1
Fujita, H; Kurata, M; Maeda, A; Matsushita, A; Mori, M; Nagai, K; Nagai, Y; Takahashi, T; Tanaka, K; Tanaka, Y; Togami, K1
Ahmad, I; André, M; Bennani, J; Bron, D; Dargent, JL; Meuleman, N; Ngirabacu, MC; Ravoet, C; Ysebrant, L1
Fadilah, SA; Leong, CF; Raja-Zahratul-Azma, RS1
Geary, CG; Whitehead, S1
De Bock, R; Haanen, C; Jehn, U1
Catovsky, D; Galton, DA; Goldman, JM; Islam, A1
Ascari, E; Cresci, R; Mazzini, G; Montecucco, CM; Riccardi, A1
Hashimoto, Y; Kanamori, H; Kitamura, H; Koike, T; Matsuzaki, M; Mohri, H; Motomura, S; Ohkubo, T; Tanabe, J1
Davidson, TG; Hoppstein, L; Stahl, RL1
Fujimura, T; Iwabuchi, A; Kawakubo, K; Kodama, A; Ohyashiki, JH; Ohyashiki, K; Toyama, K1
Fujita, H; Hirayama, M; Kohgo, Y; Kura, T; Mogi, Y; Nakaya, R; Niitsu, Y; Tsuji, N; Watanabe, N1
Dunphy, CH; Kitchen, S; Saravia, O; Velasquez, WS1
Arthur, C; Ma, DD; Nevell, DF; Straetmans, N1
Karasawa, M; Kim, K; Kobayashi, S; Koiso, H; Naruse, T; Sakai, H; Tamura, J; Tomiazwa, T; Ueki, K; Yano, S1
Ancliffe, P; Cohen, S; Griffiths, MH; Woodward, N1
Aldrighetti, L; Angeli, E; Bernardi, M; Camba, L; Ciceri, F; Giacomelli, M; Marktel, S1
Dunning, AJ1
Hotta, T; Ichikawa, A; Inoue, C; Murate, T; Saito, H; Tsushita, K1
Dommergues, JP; Garel, D; Gaulard, P; Mielot, F; Quillard, J; Tchernia, G1
García Díez, I; Palomera Bernal, L1
Donhuijsen-Ant, R; Leder, LD; Löffler, H; Schadeck-Gressel, C; Schmidt, U; Westerhausen, M1
Frickhofen, N; Heil, G; Heimpel, H; Hertenstein, B; Kurrle, E1
Levy, JM; Lutz, P; Seiller, F; Stoll, C1
Lawlor, E; McCann, SR; Murray, M; Sarsfield, P1
García Díez, I; Palomera, L; Torres, A; Velasco, F; Woessner, S1
Carter, RT; Cersosimo, RJ; Coderre, M; Karp, DD; Matthews, SJ1
Hirota, N; Kano, Y; Miura, Y; Ohsaka, A; Okada, K; Sakamoto, S; Sasaki, R; Takeda, K; Tsuboyama, A1
Birgens, HS; Geisler, C; Hansen, NE; Hasselbalch, H1
Katzman, JA; Lobato-Mendizábal, E; Marín-Lopez, A; Nichols, WL; Ruiz-Argüelles, A; Ruiz-Argüelles, GJ1
Ahlbom, G; Jensen, MK; Johansen, P1
Barcos, M; Preisler, HD; Raza, A1
Lee, SL; Rosner, F1

Reviews

4 review(s) available for cytarabine and Primary Myelofibrosis

ArticleYear
Treatment intensity significantly influencing fibrosis in bone marrow independently of the cytogenetic response: meta-analysis of the long-term results from two prospective controlled trials on chronic myeloid leukemia.
    Leukemia, 2004, Volume: 18, Issue:9

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow; Chromosome Aberrations; Controlled Clinical Trials as Topic; Cytarabine; Cytogenetic Analysis; Disease Progression; Drug Resistance, Neoplasm; Female; Humans; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Primary Myelofibrosis; Prospective Studies; Risk Factors; Survival Rate

2004
Two additional cases of acute myeloid leukemia with t(7;11)(p15;p15) having low neutrophil alkaline phosphatase scores.
    Cancer genetics and cytogenetics, 1993, Jul-15, Volume: 68, Issue:2

    Topics: Acute Disease; Adult; Alkaline Phosphatase; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 7; Cytarabine; Daunorubicin; Female; Humans; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Male; Mercaptopurine; Middle Aged; Neutrophils; Prednisolone; Primary Myelofibrosis; Remission Induction; Translocation, Genetic

1993
Acute myelofibrosis terminating in acute lymphoblastic leukemia: case report and review of the literature.
    American journal of hematology, 1996, Volume: 51, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blast Crisis; Bone Marrow; Chromosome Deletion; Chromosomes, Human, Pair 5; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Daunorubicin; Disease Progression; Flow Cytometry; Humans; Immunophenotyping; Male; Mercaptopurine; Methotrexate; Neoplastic Stem Cells; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Primary Myelofibrosis; Remission Induction; Vincristine

1996
Acute megakaryoblastic leukemia: a case report.
    Haematology and blood transfusion, 1990, Volume: 33

    Topics: Acid Phosphatase; Aged; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cytarabine; Etoposide; Humans; Leukemia, Megakaryoblastic, Acute; Male; Neoplasm Proteins; Neoplastic Stem Cells; Primary Myelofibrosis

1990

Other Studies

36 other study(ies) available for cytarabine and Primary Myelofibrosis

ArticleYear
Oral lesions in the course of myelofibrosis successfully treated using combination therapy with thalidomide, betamethasone, and cytarabine.
    Polskie Archiwum Medycyny Wewnetrznej, 2013, Volume: 123, Issue:4

    Topics: Aged; Betamethasone; Candida albicans; Cytarabine; Drug Therapy, Combination; Humans; Male; Oral Ulcer; Primary Myelofibrosis; Staphylococcus aureus; Thalidomide

2013
Sixteenth biannual report of the Cochrane Haematological Malignancies Group: focus on Non-Hodgkin's lymphoma.
    Journal of the National Cancer Institute, 2014, Volume: 106, Issue:8

    Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Boronic Acids; Bortezomib; Carmustine; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Etoposide; Hematologic Neoplasms; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Melphalan; Nitriles; Nitrogen Mustard Compounds; Prednisone; Primary Myelofibrosis; Pyrazines; Pyrazoles; Pyrimidines; Quality of Life; Randomized Controlled Trials as Topic; Rituximab; Vincristine

2014
The combination treatment regimen of ruxolitinib with low-dose mercaptopurine or cytarabine in frail patients with blast-phase myelofibrosis.
    British journal of haematology, 2017, Volume: 178, Issue:4

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Combined Modality Therapy; Cytarabine; Fatal Outcome; Female; Humans; Mercaptopurine; Middle Aged; Nitriles; Primary Myelofibrosis; Pyrazoles; Pyrimidines; Retreatment; Treatment Outcome

2017
Abnormal erythroid cell proliferation and myelofibrosis in a cat.
    The Journal of veterinary medical science, 2012, Volume: 74, Issue:7

    Topics: Anemia; Animals; Cat Diseases; Cats; Cell Proliferation; Cytarabine; Erythroid Cells; Fatal Outcome; Myelodysplastic Syndromes; Primary Myelofibrosis

2012
Long-term remission in a case of acute promyelocytic leukemia patient with marked myelofibrosis treated with arsenic trioxide, all-trans retinoic acid and consolidation therapy with daunorubicin plus cytarabine.
    Leukemia research, 2012, Volume: 36, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Consolidation Chemotherapy; Cytarabine; Daunorubicin; Female; Humans; Leukemia, Promyelocytic, Acute; Oxides; Primary Myelofibrosis; Remission Induction; Survivors; Tretinoin

2012
Successful treatment with intermediate dose cytosine arabinoside for myelodysplastic syndrome with acute myelofibrosis.
    Leukemia & lymphoma, 2003, Volume: 44, Issue:5

    Topics: Acute Disease; Cytarabine; Humans; Male; Middle Aged; Myelodysplastic Syndromes; Primary Myelofibrosis; Remission Induction; Treatment Outcome

2003
FLAG chemotherapy followed by allogeneic stem cell transplant using nonmyeloablative conditioning induces regression of myelofibrosis with myeloid metaplasia.
    Bone marrow transplantation, 2003, Volume: 32, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoiesis; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Osteosclerosis; Primary Myelofibrosis; Radionuclide Imaging; Remission Induction; Splenomegaly; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine

2003
Multiple granulocytic sarcomas in essential thrombocythemia.
    International journal of hematology, 2006, Volume: 84, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Chromosome Deletion; Chromosomes, Human, Pair 7; Cytarabine; Etoposide; Fatal Outcome; Female; Femoral Fractures; Femoral Neoplasms; Humans; Hydroxyurea; Middle Aged; Mitobronitol; Neoplasm Metastasis; Nitrosourea Compounds; Primary Myelofibrosis; Radiography; Sarcoma, Myeloid; Thrombocythemia, Essential

2006
Long-term follow-up of autologous peripheral blood stem cell transplantation in the treatment of a patient with acute panmyelosis with myelofibrosis.
    Haematologica, 2006, Volume: 91, Issue:12 Suppl

    Topics: Acute Disease; Anemia, Refractory; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Erythropoietin; Etoposide; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid; Male; Methotrexate; Middle Aged; Mitoxantrone; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Primary Myelofibrosis; Recombinant Proteins; Transplantation Conditioning; Transplantation, Autologous; Whole-Body Irradiation

2006
Extensive myelofibrosis responsive to treatment for acute erythroblastic leukaemia.
    The Malaysian journal of pathology, 2006, Volume: 28, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Female; Humans; Leukemia, Erythroblastic, Acute; Leukemia, Promyelocytic, Acute; Primary Myelofibrosis

2006
Low dose cytosine arabinoside used to induce remission in acute myelofibrosis.
    British journal of haematology, 1984, Volume: 58, Issue:2

    Topics: Acute Disease; Cytarabine; Humans; Male; Middle Aged; Primary Myelofibrosis

1984
Clinical trial of low-dose Ara-C in the treatment of acute leukemia and myelodysplasia.
    Blut, 1984, Volume: 48, Issue:5

    Topics: Anemia, Aplastic; Blood Cell Count; Cell Differentiation; Cytarabine; Dose-Response Relationship, Drug; Female; Humans; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Male; Middle Aged; Primary Myelofibrosis; Thrombocytopenia

1984
Bone marrow fibre content in acute myeloid leukaemia before and after treatment.
    Journal of clinical pathology, 1984, Volume: 37, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Collagen; Cytarabine; Daunorubicin; Humans; Leukemia, Myeloid, Acute; Podophyllotoxin; Primary Myelofibrosis; Reticulin; Thioguanine

1984
Cytokinetic changes in the peripheral blood of leukemic patients during cytostatic therapy. VI. Effect of arabinosylcytosine.
    Basic and applied histochemistry, 1980, Volume: 24, Issue:4

    Topics: Adult; Aged; Blood Cells; Cytarabine; DNA; Female; Humans; Interphase; Leukemia; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Male; Middle Aged; Primary Myelofibrosis

1980
Successful treatment of low dose cytosine arabinoside for acute myelofibrosis with immature myeloblast (AML-MO)
    American journal of hematology, 1994, Volume: 46, Issue:2

    Topics: Acute Disease; Cytarabine; Dose-Response Relationship, Drug; Female; Humans; Middle Aged; Primary Myelofibrosis

1994
Intraperitoneal chemotherapy with cytosine arabinoside in agnogenic myelofibrosis with myeloid metaplasia and ascites due to peritoneal extramedullary hematopoiesis.
    American journal of hematology, 1993, Volume: 43, Issue:2

    Topics: Aged; Ascites; Cytarabine; Hematopoiesis, Extramedullary; Humans; Injections, Intraperitoneal; Male; Peritoneum; Primary Myelofibrosis

1993
[Successful treatment with combination chemotherapy of BHAC-AMP in a case of acute myelofibrosis developed from myelodysplastic syndrome with multiple chromosomal aberrations].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1993, Volume: 34, Issue:3

    Topics: Aclarubicin; Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Chromosome Aberrations; Cytarabine; Humans; Male; Mercaptopurine; Middle Aged; Myelodysplastic Syndromes; Prednisolone; Primary Myelofibrosis

1993
Evolution of bone marrow fibrosis and stromal antigenic expression in chronic myeloid leukemia on alpha interferon and Ara-C therapy.
    Hematopathology and molecular hematology, 1996, Volume: 10, Issue:4

    Topics: Adult; Antigens; Antigens, CD; Antigens, CD34; Bone Marrow Examination; Cytarabine; E-Selectin; Endothelium; Female; Fibrosis; HLA-DR Antigens; Humans; Immunohistochemistry; Integrin beta3; Interferon-alpha; Lectins; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Plant Lectins; Platelet Endothelial Cell Adhesion Molecule-1; Platelet Membrane Glycoproteins; Primary Myelofibrosis; Reticulin; Retrospective Studies; Staining and Labeling; Stromal Cells; von Willebrand Factor

1996
Successful low-dose cytosine arabinoside treatment in a patient with acute leukemia from idiopathic myelofibrosis.
    Journal of medicine, 1999, Volume: 30, Issue:1-2

    Topics: Acute Disease; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Humans; Karyotyping; Leukemia, Myeloid; Male; Middle Aged; Primary Myelofibrosis

1999
Renal myelofibrosis: an unusual cause of renal impairment.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2000, Volume: 15, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cytarabine; Granulocyte Colony-Stimulating Factor; Hematopoiesis, Extramedullary; Humans; Kidney; Kidney Diseases; Male; Middle Aged; Primary Myelofibrosis; Vidarabine

2000
Locoregional intrasplenic chemotherapy for hypersplenism in myelofibrosis.
    British journal of haematology, 2001, Volume: 114, Issue:3

    Topics: Aged; Antimetabolites, Antineoplastic; Cytarabine; Humans; Hypersplenism; Infusions, Intra-Arterial; Male; Primary Myelofibrosis; Splenic Artery

2001
[A patient with anemia].
    Nederlands tijdschrift voor geneeskunde, 1976, Jul-10, Volume: 120, Issue:28

    Topics: Aged; Anemia; Blood Cell Count; Bone Marrow Examination; Cytarabine; Diagnosis, Differential; Female; Humans; Leukemia, Myeloid, Acute; Primary Myelofibrosis; Thioguanine

1976
[Myelodysplasia predominantly involving in megakaryocytic lineage successfully treated with low-dose Ara-C].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1991, Volume: 32, Issue:8

    Topics: Adolescent; Cytarabine; Drug Administration Schedule; Humans; Leukemia, Megakaryoblastic, Acute; Male; Myelodysplastic Syndromes; Primary Myelofibrosis

1991
Acute megakaryocytic leukemia (AMKL) with major myelofibrosis in an infant. Diagnosis by liver biopsy and response to treatment.
    Nouvelle revue francaise d'hematologie, 1991, Volume: 33, Issue:1

    Topics: Biopsy; Cytarabine; Follow-Up Studies; Humans; Infant; Leukemia, Megakaryoblastic, Acute; Liver; Male; Primary Myelofibrosis; Remission Induction

1991
[Beta-thromboglobulin and platelet factor 4 in a follow-up of acute myelofibrosis (megakaryoblastic leukemia)].
    Medicina clinica, 1990, Jun-02, Volume: 95, Issue:1

    Topics: Acute Disease; Aged; beta-Thromboglobulin; Cytarabine; Female; Follow-Up Studies; Humans; Leukemia, Megakaryoblastic, Acute; Platelet Factor 4; Primary Myelofibrosis; Time Factors

1990
Aggressive polychemotherapy for acute myelofibrosis.
    European journal of haematology, 1990, Volume: 44, Issue:4

    Topics: Acute Disease; Adult; Aged; Bone Marrow; Cytarabine; Daunorubicin; Drug Therapy, Combination; Erythrocyte Count; Female; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Megakaryocytes; Middle Aged; Primary Myelofibrosis; Thioguanine

1990
[Megakaryoblastic leukemia with hypodiploidy in a girl with trisomy 21].
    Annales de pediatrie, 1985, Volume: 32, Issue:6

    Topics: Blood Platelets; Bone Marrow; Child, Preschool; Chromosome Aberrations; Chromosome Disorders; Cytarabine; Down Syndrome; Female; Humans; Leukemia; Primary Myelofibrosis

1985
Low dose cytosine arabinoside in the treatment of myeloid leukaemias and myelodysplastic syndromes.
    Irish journal of medical science, 1988, Volume: 157, Issue:7

    Topics: Aged; Cytarabine; Dose-Response Relationship, Drug; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Primary Myelofibrosis

1988
[Megakaryoblastic leukemia (acute myelofibrosis): complete remission of a case with low-dose cytosine arabinoside].
    Sangre, 1988, Volume: 33, Issue:3

    Topics: Aged; Calcitriol; Cytarabine; Female; Humans; Leukemia, Megakaryoblastic, Acute; Primary Myelofibrosis; Remission Induction

1988
Acute cerebellar syndrome, conjunctivitis, and hearing loss associated with low-dose cytarabine administration.
    Drug intelligence & clinical pharmacy, 1987, Volume: 21, Issue:10

    Topics: Aged; Cerebellar Diseases; Conjunctivitis; Cytarabine; Hearing Disorders; Humans; Male; Primary Myelofibrosis

1987
[Diminished bone marrow fibrosis on autopsy in a patient with acute myelofibrosis following chemotherapy].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1986, Volume: 27, Issue:9

    Topics: Acute Disease; Bone Marrow; Cytarabine; Daunorubicin; Humans; Male; Middle Aged; Primary Myelofibrosis

1986
Hypercalcaemia in the accelerated phase of chronic myelogenous leukaemia: no relationship to the phenotype of the blast cells.
    Scandinavian journal of haematology, 1985, Volume: 35, Issue:3

    Topics: Adult; Bone Marrow Examination; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Hydroxyurea; Hypercalcemia; Leukemia, Myeloid; Male; Methotrexate; Middle Aged; Phenotype; Primary Myelofibrosis

1985
Acute megakaryoblastic leukaemia: a prospective study of its identification and treatment.
    British journal of haematology, 1986, Volume: 62, Issue:1

    Topics: Acute Disease; Adolescent; Adult; Bone Marrow; Child; Cytarabine; Female; Hematologic Tests; Humans; Male; Primary Myelofibrosis; Prospective Studies; Thrombocythemia, Essential

1986
Low-dose cytosine arabinoside therapy in a patient with myelofibrosis during transformation to acute non-lymphocytic leukemia.
    Acta medica Scandinavica, 1986, Volume: 219, Issue:1

    Topics: Cytarabine; Dose-Response Relationship, Drug; Humans; Leukemia; Lymphocyte Activation; Male; Middle Aged; Primary Myelofibrosis

1986
Treatment of dysmyelopoietic/leukemic syndromes with myelofibrosis and megakaryocytic hyperplasia with large doses of cytosine arabinoside.
    Medical oncology and tumor pharmacotherapy, 1985, Volume: 2, Issue:2

    Topics: Acute Disease; Adult; Aged; Biopsy; Blood Cell Count; Bone Marrow; Cytarabine; Dose-Response Relationship, Drug; Female; Humans; Hyperplasia; Leukemia; Male; Megakaryocytes; Middle Aged; Myelodysplastic Syndromes; Pancytopenia; Primary Myelofibrosis; Thrombocythemia, Essential

1985
Treatment of AGL.
    Archives of internal medicine, 1969, Volume: 123, Issue:2

    Topics: Adult; Afibrinogenemia; Aged; Anemia; Antineoplastic Agents; Child; Cytarabine; Daunorubicin; Humans; Hydroxyzine; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Leukopenia; Mercaptopurine; Methotrexate; Middle Aged; Polycythemia Vera; Prednisone; Primary Myelofibrosis; Splenomegaly; Vincristine

1969